ImageneBio, Inc. Profit Breakdown
Profit breakdown shows how much each product earned: one column per product, one row per year or quarter. All amounts are the filed figures for that period.
- ImageneBio, Inc. revenue for the quarter ending 2025-12-31 was $0.00, a change of $0.00 year-over-year.
- ImageneBio, Inc. revenue for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ImageneBio, Inc. revenue for the quarter ending 2025-06-30 was $0.00.
- ImageneBio, Inc. revenue for the quarter ending 2025-03-31 was $800,000.00.
- ImageneBio, Inc. revenue for fiscal 2025 was $800,000.00, a 77.14% decline from fiscal 2024.
- ImageneBio, Inc. revenue for fiscal 2024 was $3.5M, a 61.79% decline from fiscal 2023.
- ImageneBio, Inc. revenue for fiscal 2023 was $9.16M, a 41.35% decline from fiscal 2022.
- ImageneBio, Inc. revenue for fiscal 2022 was $15.62M, a 49.59% decline from fiscal 2021.
- Available history
- 2020-03-31 to 2026-06-30
- Data captured
Profit by product
ImageneBio, Inc. did not file profit by product.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |